Table 1.
C5D5N | ||
---|---|---|
Apicidin L | ||
Position | δC/ppm, type | δH/ppm, m, (J in Hz) |
N-methoxytryptophane | ||
NH | 9.96, d (6.7) | |
1 | 175.1, C | |
2 | 62.5, CH | 4.48, dt (9.6, 7.0) |
3 | 26.0, CH2 |
4.24–4.14, m 3.87, dd (14.5, 7.3) |
4 | 108.7, C | |
4a | 124.7, C | |
5 | 119.9, CH | 7.74, d (7.9) |
6 | 120.7, CH | 7.18, t (7.0) |
7 | 123.4, CH | 7.36–7.30, m |
8 | 109.4, CH | 7.53, d (8.1) |
8a | 133.4, C | |
9 | 123.3, CH | 7.50–7.43, m |
10 | 66.2, CH3 | 3.91, s |
2-amino-8-hydroxy-octanoic acid | ||
NH′ | 7.86, d (10.0) | |
1′ | 176.7, C | |
2′ | 55.8, CH | 4.75, ddd (10.0, 8.4, 6.8) |
3′ | 30.9, CH2 |
2.06–1.89, m 1.66–1.60, m |
4′ | 26.7, CH2 | 1.30–1.18, m |
5′ | 29.9, CH2 | 1.30–1.18, m |
6′ | 26.6, CH2 | 1.50–1.31, m |
7′ | 34.1, CH2 | 1.66–1.60, m |
8′ | 62.4, CH2 | 3.81, t (6.5) |
OH′ | 5.10, s | |
proline | ||
1″ | 172.4, C | |
2″ | 58.6, CH | 5.03–4.95, m |
3″ | 25.5, CH2 |
2.38–2.30, m 1.50–1.38, m |
4″ | 25.4, CH2 |
2.11, dt (18.0, 6.8) 1.60–1.51, m |
5″ | 47.2, CH2 |
4.11, dd (9.6, 3.9) 3.35, dt (10.1,8.1) |
Phenylalanine | ||
NH‴ | 8.55, d (10.1) | |
1‴ | 173.9, C | |
2‴ | 54.3, CH | 5.61, ddd (10.2, 8.7, 6.8) |
3‴ | 37.2, CH2 |
3.54, dd (13.6, 8.7) 3.28, dd (13.6, 6.8) |
4‴ | 138.6, C | |
5/9‴ | 130.2, CH | 7.50–7.43, m |
6/8‴ | 129.4, CH | 7.36–7.30, m |
7‴ | 127.5, CH | 7.25, t (8.1) |
1H NMR was recorded at 600 MHz, 13C NMR was recorded at 150 MHz in C5D5N